SHIFTBIO
PrivateLast Round
VC Round
Feb 1, 2024
Company Overview
SHIFTBIO operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a VC Round in February 2024.
SHIFTBIO is a biotechnology company that develops a nanoparticle-based drug delivery system designed for targeted therapeutic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SHIFTBIO Comparables
Compare SHIFTBIO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Evox Therapeutics | 83% | |
| ILIAS Biologics Inc. | 81% | |
| Exocure | 79% |
For institutional investors. Book with your work email.
SHIFTBIO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 1, 2024 | ||||
| Accelerator | Jun 3, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
SHIFTBIO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Korea University Holdings | Accelerator |
| Korea Credit Guarantee Fund | Accelerator |
| Government of South Korea | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 254% MoM.
- Oct 29, 2024
Monthly visitors grew 182% MoM.
For institutional investors. Book with your work email.
SHIFTBIO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about SHIFTBIO's valuation, stock price, and market status.
Is SHIFTBIO a public or private company?
SHIFTBIO is a private company.
What is the current stock price of SHIFTBIO?
SHIFTBIO is a private company, so its shares have no public market price. Caplight tracks SHIFTBIO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SHIFTBIO worth (valuation)?
Valuation information for SHIFTBIO is not publicly available.
Can I buy SHIFTBIO stock?
SHIFTBIO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SHIFTBIO's last funding round?
SHIFTBIO's most recent funding round was VC Round on February 1, 2024.
Who are the main investors in SHIFTBIO?
Key investors in SHIFTBIO include Korea University Holdings, Korea Credit Guarantee Fund, Government of South Korea.
Will SHIFTBIO IPO soon?
No public IPO plans have been announced for SHIFTBIO.
How can I track SHIFTBIO secondary market activity?
Caplight tracks bids, offers, and trades in SHIFTBIO's shares on secondary markets.